MAGNASENSE ABMAGNASENSE ABMAGNASENSE AB

MAGNASENSE AB

No trades
See on Supercharts
Market capitalization
‪706.21 K‬EUR
‪−5.34 M‬EUR
‪8.23 K‬EUR
‪35.78 M‬
Beta (1Y)
1.41

About MAGNASENSE AB


CEO
Marco Witteveen
Headquarters
Lund
Founded
2019
ISIN
SE0014401121
FIGI
BBG00VVPS9S1
Magnasense AB engages in the development and commercialization of drug monitoring tests. Its products include Viraspec COVID-19 Saliva Test and moNATor. The company was founded on September 26, 2019 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MAGNASENSE AB stocks are traded under the ticker 52Q.
52Q reached its all-time high on Jul 28, 2021 with the price of 41.0000 EUR, and its all-time low was 0.0096 EUR and was reached on Nov 22, 2024. View more price dynamics on 52Q chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track MAGNASENSE AB financials in yearly and quarterly reports right on TradingView.
52Q net income for the last quarter is ‪−1.17 M‬ EUR, while the quarter before that showed ‪−704.74 K‬ EUR of net income which accounts for −65.92% change. Track more MAGNASENSE AB financial stats to get the full picture.
No, 52Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 52Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAGNASENSE AB stock right from TradingView charts — choose your broker and connect to your account.